1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Huiyan Bio

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2013

Location

Wuhan Hubei China

Primary Industry

Biotechnology

About

Based in Wuhan, China, and established in 2013, Huiyan Bio operates as a biotechnology company that focuses on providing mediums and equipment used in separation and purification. The company passed the ISO9001 system certification and was recognized as the National High-tech Enterprise. It also acquired 6 invention patents. In November 2020, Huiyan Bio closed series A funding from new investor Greenriver Capital. Huiyan Bio mainly provides technical services such as protein, antibody, peptide, and nucleic acid isolation and purification. The company mainly provides gel filtration, ion exchange, and hydrophobic chromatography media, and chromatography columns. Agarose gel filtration medium, Focurose 4B, is suitable for the separation of components and medium purification of biomolecular substances, such as virus particles and recombinant hepatitis B surface antigen. Its products and services can be used in biotechnology, biopharmaceuticals, diagnostic reagents, biologics, and medical devices.
Current Investors
Greenriver Capital

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Medical Equipment Distributors
Website
www.huiyan-bio.com
Verticals
Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.